Discontinued — last reported Q4 '25
Ellington Financial Inc. Equity Method Investments decreased by 24.4% to -$39.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 24.4%, from -$31.73M to -$39.48M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a 92.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | -$13.20M | -$13.00M | -$31.73M | -$39.48M |
| QoQ Change | — | — | +1.5% | -144.1% | -24.4% |
| YoY Change | — | — | +1.5% | -144.1% | -24.4% |